Prevalence of mutations in AGPAT2 among human lipodystrophies

Diabetes

Volumn 52, Issue 6, 2003, Pages 1573-1578

  Magré, Jocelyne ^a   Delépine, Marc ^b   Van Maldergem, Lionel ^c   Robert, Jean Jacques ^d   Maassen, J Antonie ^e   Meier, Muriel ^a   Panz, Vanessa R ^f   Kim, Chong Ae ^g   Tubiana Rufi, Nadia ^h   Czernichow, Paul ^h   Seemanova, Eva ⁱ   Buchanan, Charles R ^j   Lacombe, Didier ^k   Vigouroux, Corinne ^a   Lascols, Olivier ^a   Kahn, C Ronald ^l   Capeau, Jacqueline ^a   Lathrop, Mark ^b  

^a INSERM   (France)

^b CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^c INSTITUTE OF PATHOLOGY AND GENETICS   (Belgium)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e LEIDEN UNIVERSITY   (Netherlands)

^f UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

^h HÔPITAL ROBERT DEBRÉ   (France)

ⁱ CHARLES UNIVERSITY   (Czech Republic)

^j KING S COLLEGE HOSPITAL   (United Kingdom)

^k HÔPITAL PELLEGRIN   (France)

^l HARVARD UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

1 ACYLGLYCEROL 3 PHOSPHATE ACYLTRANSFERASE BETA; ACYLTRANSFERASE; ALANINE; GLUTAMIC ACID; GLYCINE; LYSINE; PROTEIN; PROTEIN AGPAT 1; PROTEIN AGPAT 2; SEIPIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BERARDINELLI SEIP CONGENITAL LIPODYSTROPHY; CLINICAL ARTICLE; CLINICAL FEATURE; GENE MUTATION; GENETIC SCREENING; HUMAN; INSULIN RESISTANCE; LIPODYSTROPHY; MISSENSE MUTATION; PATHOGENESIS; PEDIGREE; PRIORITY JOURNAL;

1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; ACYLTRANSFERASES; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 9; DNA PRIMERS; FEMALE; GTP-BINDING PROTEIN GAMMA SUBUNITS; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; LIPODYSTROPHY; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE;

EID: 0037982806     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.6.1573     Document Type: Article

References (25)

1. Seip M, Trygstad O: Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr Suppl 413:2-28, 1996
2. Reitman ML, Arioglu E, Gavrilova O, Taylor SI: Lipoatrophy revisited. Trends Endocrinol Metab 11:410-416, 2000
3. Garg A: Lipodystrophies. Am J Med 108:143-152, 2000
4. Bhayana S, Hegele RA: The molecular basis of genetic lipodystrophies. Clin Biochem 35:171-177, 2002
5. Lawrence RD: Lipodystrophy and hepatomegaly with diabetes, lipemia and other metabolic disturbances. Lancet 1:724-741, 1946
6. Magré J, Delépine M, Khallouf E, Gedde-Dahl T Jr, Van Maldergem L, Sobel E, Papp J, Meier M, MÅgarbané A, Bachy A, Verloes A, d'Abronzo FH, Seemanova E, Assan R, Baudic N, Bourut C, Czernichow P, Huet F, Grigorescu F, de Kerdanet M, Lacombe D, Labrune P, Lanza M, Loret H, Matsuda F, Navarro J, Nivelon-Chevalier A, Polak M, Robert JJ, Tric P, Tubiana-Rufi N, Vigouroux C, Weissenbach J, Savasta S, Maassen JA, Trygstad O, Bogalho P, Freitas P, Medina JL, Bonnicci F, Joffe BI, Loyson G, Panz VR, Raal FJ, O'Rahilly S, Stephenson T, Kahn CR, Lathrop M, Capeau J: Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet 28:365-370, 2001
7. Agarwal AK, Arioglu E, De Almeida S, Akkoc N, Taylor SI, Bowcock AM, Barnes RI, Garg A: AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet 31:21-23, 2002
8. Heathcote K, Rajab A, Magré J, Syrris P, Besti M, Patton M, Delépine M, Lathrop M, Capeau J, Jeffery S: Molecular analysis of Berardinelli-Seip congenital lipodystrophy in Oman: evidence for multiple loci. Diabetes 51:1291-1293, 2002
9. Van Maldergem L, Magré J, Gedde-DahlJr T, Khallouf E, Delépine M, Trygstad O, Seemova E, Stephenson T, Albott C, Bonnici F, Panz V, Medina J-L, Bogalho P, Huet F, Savasta S, Verloes A, Robert J-J, Loret H, de Kerdanet M, Mégarbané A, Tubiana-Rufi N, Maassen A, Polak M, Lacombe D, Kahn C, Silveira E, d'Abronzo H, Grigorescu F, Lathrop M, Capeau J, O'Rahilly S: Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy. J Med Genet 39:722-733, 2002
10. Bhayana S, Siu VM, Joubert GI, Clarson CL, Cao H, Hegele RA: Cardiomyopathy in congenital complete lipodystrophy. Clin Genet 61:283-287, 2002
11. Eberhardt C, Gray PW, Tjoelker LW: Human lysophosphatidic acid acyltransferase: cDNA cloning, expression, and localization to chromosome 9q34.3. J Biol Chem 272:20299-20305, 1997
12. Eberhardt C, Gray PW, Tjoelker LW: cDNA cloning, expression and chromosomal localization of two human lysophosphatidic acid acyltransferases. Adv Exp Med Biol 469:351-356, 1999
13. Leung DW: The structure and functions of human lysophosphatidic acid acyltransferases. Front Biosci 6:D944-D953, 2001
14. Strachan T, Read AP: In Human Molecular Genetics. Oxford, U.K., BIOS Scientific Publishers Ltd, 1996
15. Kawaji H, Schonbach C, Matsuo Y, Kawai J, Okazaki Y, Hayashizaki Y, Matsuda H: Exploration of novel motifs derived from mouse cDNA sequences. Genome Res 12:367-378, 2002
16. Lewin TM, Wang P, Coleman RA: Analysis of amino acid motifs diagnostic for the sn-glycerol-3-phosphate acyltransferase reaction. Biochemistry 38:5764-5771, 1999
17. Ruan H, Pownall HJ: Overexpression of 1-acyl-glycerol-3-phosphate acyltransferase-α enhances lipid storage in cellular models of adipose tissue and skeletal muscle. Diabetes 50:233-240, 2001
18. Hübler A, Abendroth K, Keiner T, Stocker W, Kauf E, Hein G, Stein G: Dysregulation of insulin-like growth factors in a case of generalized acquired lipoatrophic diabetes mellitus (Lawrence Syndrome) connected with autoantibodies against adipocyte membranes. Exp Clin Endocrinol Diabetes 106:79-84, 1998
19. Desbois-Mouthon C, Magré J, Amselem S, Reynet C, Blivet MJ, Goossens M, Capeau J, Besmond C: Lipoatrophic diabetes: genetic exclusion of the insulin receptor gene. J Clin Endocrinol Metab 80:314-319, 1995
20. Panz VR, Raal FJ, O'Rahilly S, Kedda MA, Joffe BI: Insulin receptor substrate-1 gene variants in lipoatrophic diabetes mellitus and non-insulindependent diabetes mellitus: a study of South African black and white subjects. Hum Genet 101:118-119, 1997
21. Okazawa H, Mori H, Tamori Y, Araki S, Niki T, Masugi J, Kawanishi M, Kubota T, Shinoda H, Kasuga M: No coding mutations are detected in the peroxisome proliferator-activated receptor-γ gene in Japanese patients with lipoatrophic diabetes. Diabetes 46:1904-1906, 1997
22. Vigouroux C, Magré J, Vantyghem MC, Bourut C, Lascols O, Shackleton S, Lloyd DJ, Guerci B, Padova G, Valensi P, Grimaldi A, Piquemal R, Touraine P, Trembath RC, Capeau J: Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Diabetes 49:1958-1962, 2000
23. Vigouroux C, Khallouf E, Bourut C, Robert JJ, de Kerdanet M, Tubiana-Rufi N, Faure S, Weissenbach J, Capeau J, Magré J: Genetic exclusion of 14 candidate genes in lipoatropic diabetes using linkage analysis in 10 consanguineous families. J Clin Endocrinol Metab 82:3438-3444, 1997
24. Vigouroux C, Fajas L, Khallouf E, Meier M, Gyapay G, Lascols O, Auwerx J, Weissenbach J, Capeau J, Magré J: Human peroxisome proliferatoractivated receptor-γ2: genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes. Diabetes 47:490-492, 1998
25. Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, Roth J: The syndromes of insulin resistance and acanthosis nigricans: insulin-receptor disorders in man. N Engl J Med 294:739-745, 1976